BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6354523)

  • 1. Studies on the treatment of idiopathic gynaecomastia with percutaneous dihydrotestosterone.
    Kuhn JM; Roca R; Laudat MH; Rieu M; Luton JP; Bricaire H
    Clin Endocrinol (Oxf); 1983 Oct; 19(4):513-20. PubMed ID: 6354523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 10 days administration of percutaneous dihydrotestosterone on the pituitary-testicular axis in normal men.
    Kuhn JM; Rieu M; Laudat MH; Forest MG; Pugeat M; Bricaire H; Luton JP
    J Clin Endocrinol Metab; 1984 Feb; 58(2):231-5. PubMed ID: 6363434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of persistent pubertal gynecomastia with dihydrotestosterone heptanoate.
    Eberle AJ; Sparrow JT; Keenan BS
    J Pediatr; 1986 Jul; 109(1):144-9. PubMed ID: 3088241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact level of dihydrotestosterone on the hypothalamic-pituitary-leydig cell axis in men.
    Cailleux-Bounacer A; Rohmer V; Lahlou N; Lefebvre H; Roger M; Kuhn JM
    Int J Androl; 2009 Feb; 32(1):57-65. PubMed ID: 17931384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual administration of testosterone-hydroxypropyl-beta-cyclodextrin inclusion complex simulates episodic androgen release in hypogonadal men.
    Stuenkel CA; Dudley RE; Yen SS
    J Clin Endocrinol Metab; 1991 May; 72(5):1054-9. PubMed ID: 1902483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In older men an optimal plasma testosterone is associated with reduced all-cause mortality and higher dihydrotestosterone with reduced ischemic heart disease mortality, while estradiol levels do not predict mortality.
    Yeap BB; Alfonso H; Chubb SA; Handelsman DJ; Hankey GJ; Almeida OP; Golledge J; Norman PE; Flicker L
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E9-18. PubMed ID: 24257908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men.
    Meikle AW; Mazer NA; Moellmer JF; Stringham JD; Tolman KG; Sanders SW; Odell WD
    J Clin Endocrinol Metab; 1992 Mar; 74(3):623-8. PubMed ID: 1740497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal men.
    Jockenhövel F; Vogel E; Kreutzer M; Reinhardt W; Lederbogen S; Reinwein D
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):61-71. PubMed ID: 8796140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reference ranges and determinants of testosterone, dihydrotestosterone, and estradiol levels measured using liquid chromatography-tandem mass spectrometry in a population-based cohort of older men.
    Yeap BB; Alfonso H; Chubb SA; Handelsman DJ; Hankey GJ; Norman PE; Flicker L
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4030-9. PubMed ID: 22977273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human chorionic gonadotropin but not dihydrotestosterone alone stimulates osteoblastic collagen synthesis in older men with partial age-related androgen deficiency.
    Meier C; Liu PY; Ly LP; de Winter-Modzelewski J; Jimenez M; Handelsman DJ; Seibel MJ
    J Clin Endocrinol Metab; 2004 Jun; 89(6):3033-41. PubMed ID: 15181095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gynecomastia: effect of prolonged treatment with dihydrotestosterone by the percutaneous route].
    Kuhn JM; Laudat MH; Roca R; Dugue MA; Luton JP; Bricaire H
    Presse Med; 1983 Jan; 12(1):21-5. PubMed ID: 6220269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone with dutasteride, but not anastrazole, improves insulin sensitivity in young obese men: a randomized controlled trial.
    Juang PS; Peng S; Allehmazedeh K; Shah A; Coviello AD; Herbst KL
    J Sex Med; 2014 Feb; 11(2):563-73. PubMed ID: 24344872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of diagnostic criteria for Leydig cell tumours in adult men revealed by gynaecomastia.
    Kuhn JM; Mahoudeau JA; Billaud L; Joly J; Rieu M; Gancel A; Archambeaud-Mouveroux F; Steg A; Luton JP
    Clin Endocrinol (Oxf); 1987 Apr; 26(4):407-16. PubMed ID: 3308189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of testosterone and dihydrotestosterone in spontaneous gynecomastia of adolescents.
    Villalpando S; Mondragón L; Barrón C; Pérez-Pastén E; Castañeda G; Alonso-Uriarte R; Cortés-Gallegos V
    Arch Androl; 1992; 28(3):171-6. PubMed ID: 1530365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decline of plasma 5alpha-dihydrotestosterone (DHT) levels upon testosterone administration to elderly men with subnormal plasma testosterone and high DHT levels.
    Gooren LJ; Saad F; Haide A; Yassin A
    Andrologia; 2008 Oct; 40(5):298-302. PubMed ID: 18811920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of transdermal dihydrotestosterone in the aging male: a prospective, randomized, double blind study.
    Kunelius P; Lukkarinen O; Hannuksela ML; Itkonen O; Tapanainen JS
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1467-72. PubMed ID: 11932266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacokinetics of three doses of percutaneous dihydrotestosterone gel in healthy elderly men--a clinical research center study.
    Wang C; Iranmanesh A; Berman N; McDonald V; Steiner B; Ziel F; Faulkner SM; Dudley RE; Veldhuis JD; Swerdloff RS
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2749-57. PubMed ID: 9709942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Testosterone and estradiol levels in male gynecomastia. Clinical and endocrine findings during treatment with tamoxifen].
    Eversmann T; Moito J; von Werder K
    Dtsch Med Wochenschr; 1984 Nov; 109(44):1678-82. PubMed ID: 6489180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher serum testosterone and dihydrotestosterone, but not oestradiol, are independently associated with favourable indices of lung function in community-dwelling men.
    Mohan SS; Knuiman MW; Divitini ML; James AL; Musk AW; Handelsman DJ; Beilin J; Hunter M; Yeap BB
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):268-76. PubMed ID: 25660119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.